
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma
Kai Wang, Man Zhang, Jiao Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Kai Wang, Man Zhang, Jiao Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Showing 11 citing articles:
The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis
Chuanlong Zhang, Qian Shen, Mengqi Gao, et al.
Heliyon (2024), pp. e26061-e26061
Open Access | Times Cited: 6
Chuanlong Zhang, Qian Shen, Mengqi Gao, et al.
Heliyon (2024), pp. e26061-e26061
Open Access | Times Cited: 6
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
Jiaru Hu, Qing He, Tian Tian, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 197-210
Open Access | Times Cited: 13
Jiaru Hu, Qing He, Tian Tian, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 197-210
Open Access | Times Cited: 13
In situ tailored confining microenvironment for lung cancer spheroids
Yixiao Dong, Shuyi Qian, Xuechun Wang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101602-101602
Open Access
Yixiao Dong, Shuyi Qian, Xuechun Wang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101602-101602
Open Access
Exploring novel biomarkers and immunotherapeutic targets for biofeedback therapies to reveal the tumor-associated immune microenvironment through a multimetric analysis of kidney renal clear cell carcinoma
Guobing Wang, Jinbang Huang, Haiqing Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Guobing Wang, Jinbang Huang, Haiqing Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways
Yuzhu Tang, Xiao-Hua Lan, Maohui Yan, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 2, pp. 128-138
Open Access | Times Cited: 2
Yuzhu Tang, Xiao-Hua Lan, Maohui Yan, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 2, pp. 128-138
Open Access | Times Cited: 2
Cisplatin-Functionalized Dual-Functional Bone Substitute Granules for Bone Defect Treatment after Bone Tumor Resection
Zhule Wang, Mark Kregel, Jean-Luc Meijers, et al.
Acta Biomaterialia (2024) Vol. 191, pp. 158-176
Open Access | Times Cited: 2
Zhule Wang, Mark Kregel, Jean-Luc Meijers, et al.
Acta Biomaterialia (2024) Vol. 191, pp. 158-176
Open Access | Times Cited: 2
Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’ prognosis
Xiaobin Wang, Jiakuan Chen, Chaofan Li, et al.
PeerJ (2024) Vol. 12, pp. e17545-e17545
Open Access | Times Cited: 1
Xiaobin Wang, Jiakuan Chen, Chaofan Li, et al.
PeerJ (2024) Vol. 12, pp. e17545-e17545
Open Access | Times Cited: 1
An in-silico approach leads to explore six genes as a molecular signatures of lung adenocarcinoma.
Mostafa A. Abdel-Maksoud, Fatima Hassan, Uzma Mubarik, et al.
PubMed (2023) Vol. 13, Iss. 3, pp. 727-757
Closed Access | Times Cited: 3
Mostafa A. Abdel-Maksoud, Fatima Hassan, Uzma Mubarik, et al.
PubMed (2023) Vol. 13, Iss. 3, pp. 727-757
Closed Access | Times Cited: 3
Comprehensive analysis of roles of atrial-fibrillation-related genes in lung adenocarcinoma using bioinformatic methods
Tao Yan, Miao Zhu, Fan Weng, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 2
Tao Yan, Miao Zhu, Fan Weng, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 2
Unravelling the complexity of kidney renal clear cell carcinoma prognosis: integrating chromatin regulators, gene signatures and associated immune landscapes
Guobing Wang, Jinbang Huang, Haiqing Chen, et al.
Research Square (Research Square) (2023)
Open Access
Guobing Wang, Jinbang Huang, Haiqing Chen, et al.
Research Square (Research Square) (2023)
Open Access
CKS1B promotes the growth of ovarian cancer cells by regulating the expression of PD-L1
Yuanyuan Zuo, Yuejun Sun, Guihong Dai
European Journal of Gynaecological Oncology (2023) Vol. 44, Iss. 6, pp. 150-150
Open Access
Yuanyuan Zuo, Yuejun Sun, Guihong Dai
European Journal of Gynaecological Oncology (2023) Vol. 44, Iss. 6, pp. 150-150
Open Access